Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To compare progression-free survival (PFS) between the two treatment arms based on assessments by an independent review facility (IRF).
Critère d'inclusion
- HER2 positive metastatic breast cancer which has progressed after one line of trastuzumab-based therapy in the metastatic setting